AAAAAA

   
Results: 1-25 | 26-42
Results: 1-25/42
CD44 ISOFORMS DISTINGUISH BETWEEN BONE-MARROW PLASMA-CELLS FROM NORMAL INDIVIDUALS AND PATIENTS WITH MULTIPLE-MYELOMA AT DIFFERENT STAGES OF DISEASE
Authors: VANDRIEL M GUNTHERT U STAUDER R JOLING P LOKHORST HM BLOEM AC
Citation: M. Vandriel et al., CD44 ISOFORMS DISTINGUISH BETWEEN BONE-MARROW PLASMA-CELLS FROM NORMAL INDIVIDUALS AND PATIENTS WITH MULTIPLE-MYELOMA AT DIFFERENT STAGES OF DISEASE, Leukemia, 12(11), 1998, pp. 1821-1828
VAD AND INTERMEDIATE-DOSE MELPHALAN (IDM) INDUCTION THERAPY FOLLOWED BY STEM-CELL TRANSPLANTATION IN MULTIPLE-MYELOMA - RESULTS OF A PHASE-II AND PRELIMINARY-RESULTS OF A RANDOMIZED PHASE-III STUDY
Authors: LOKHORST HM SONNEVELD P CORNELISSEN JJ CROOCKEWIT S VANDERHOLT B KOOY MV VANOERS RHJ RICHEL D SEGEREN C VELLENGA E VERDONCK LF VERHOEF G WIJERMANS PW
Citation: Hm. Lokhorst et al., VAD AND INTERMEDIATE-DOSE MELPHALAN (IDM) INDUCTION THERAPY FOLLOWED BY STEM-CELL TRANSPLANTATION IN MULTIPLE-MYELOMA - RESULTS OF A PHASE-II AND PRELIMINARY-RESULTS OF A RANDOMIZED PHASE-III STUDY, Bone marrow transplantation, 21, 1998, pp. 709-709
MULTIDRUG-RESISTANT ACUTE-LEUKEMIA CELLS ARE RESPONSIVE TO PROLONGED EXPOSURE OF DAUNORUBICIN - IMPLICATIONS FOR LIPOSOME-ENCAPSULATED DAUNORUBICIN
Authors: VERDONCK LF LOKHORST HM ROOVERS DJ VANHEUGTEN HG
Citation: Lf. Verdonck et al., MULTIDRUG-RESISTANT ACUTE-LEUKEMIA CELLS ARE RESPONSIVE TO PROLONGED EXPOSURE OF DAUNORUBICIN - IMPLICATIONS FOR LIPOSOME-ENCAPSULATED DAUNORUBICIN, Leukemia research, 22(3), 1998, pp. 249-256
PUTATIVE MYELOMA PRECURSOR CELLS EXPRESSING 2,6-SIALIC-ACID-MODIFIED ANTIGENS ACTUALLY BELONG TO THE ERYTHROID LINEAGE
Authors: DELAU WBM KUIPERS J PETERS PJ LOKHORST HM CLEVERS H BAST BJEG
Citation: Wbm. Delau et al., PUTATIVE MYELOMA PRECURSOR CELLS EXPRESSING 2,6-SIALIC-ACID-MODIFIED ANTIGENS ACTUALLY BELONG TO THE ERYTHROID LINEAGE, Leukemia research, 22(2), 1998, pp. 163-173
CHIMERIC ANTI-INTERLEUKIN-6 MONOCLONAL-ANTIBODIES IN THE TREATMENT OFADVANCED MULTIPLE-MYELOMA - A PHASE-I DOSE-ESCALATING STUDY
Authors: VANZAANEN HCT LOKHORST HM AARDEN LA RENSINK HJAM WARNAAR SO VANDERLELIE J VANOERS MHJ
Citation: Hct. Vanzaanen et al., CHIMERIC ANTI-INTERLEUKIN-6 MONOCLONAL-ANTIBODIES IN THE TREATMENT OFADVANCED MULTIPLE-MYELOMA - A PHASE-I DOSE-ESCALATING STUDY, British Journal of Haematology, 102(3), 1998, pp. 783-790
VAD AND INTERMEDIATE-DOSE MELPHALAN (IDM) FOLLOWED BY STEM-CELL TRANSPLANTATION IN MULTIPLE-MYELOMA - RESULTS OF A PHASE-II AND PRELIMINARY-RESULTS OF A RANDOMIZED PHASE-III STUDY
Authors: LOKHORST HM SONNEVELD P CORNELISSEN JJ CROOCKEWIT S VANDERHOLT B KOOY MV VANOERS RHJ RICHEL D SEGEREN C VELLENGA E VERDONCK LF VERHOEF G WIJERMANS PW
Citation: Hm. Lokhorst et al., VAD AND INTERMEDIATE-DOSE MELPHALAN (IDM) FOLLOWED BY STEM-CELL TRANSPLANTATION IN MULTIPLE-MYELOMA - RESULTS OF A PHASE-II AND PRELIMINARY-RESULTS OF A RANDOMIZED PHASE-III STUDY, British Journal of Haematology, 102(1), 1998, pp. 6-7
POSSIBLE INVOLVEMENT OF BCL-2 BAX IN THE PATHOGENESIS AND DRUG-RESISTANCE OF MULTIPLE-MYELOMA/
Authors: DEWEERDT O VANVLIET M ROOVERS DJ BLOEM AC LOKHORST HM
Citation: O. Deweerdt et al., POSSIBLE INVOLVEMENT OF BCL-2 BAX IN THE PATHOGENESIS AND DRUG-RESISTANCE OF MULTIPLE-MYELOMA/, British Journal of Haematology, 102(1), 1998, pp. 346-346
SENSITIVITY OF MYELOMA CELLS TO CYTOTOXIC DRUGS IS DETERMINED BY INTRACELLULAR BCL-2 BAX RATIOS/
Authors: ROOVERS DJ VANVLIET M DEWEERDT O BLOEM AC LOKHORST HM
Citation: Dj. Roovers et al., SENSITIVITY OF MYELOMA CELLS TO CYTOTOXIC DRUGS IS DETERMINED BY INTRACELLULAR BCL-2 BAX RATIOS/, British Journal of Haematology, 102(1), 1998, pp. 347-347
IDARUBICIN OVERCOMES P-GLYCOPROTEIN-RELATED MULTIDRUG-RESISTANCE - COMPARISON WITH DOXORUBICIN AND DAUNORUBICIN IN HUMAN MULTIPLE-MYELOMA CELL-LINES
Authors: ROOVERS DJ VANVLIET M MARTINOTTI A DEBESI P SMEELS J BLOEM AC LOKHORST HM
Citation: Dj. Roovers et al., IDARUBICIN OVERCOMES P-GLYCOPROTEIN-RELATED MULTIDRUG-RESISTANCE - COMPARISON WITH DOXORUBICIN AND DAUNORUBICIN IN HUMAN MULTIPLE-MYELOMA CELL-LINES, British Journal of Haematology, 102(1), 1998, pp. 354-354
LONG-TERM BONE-MARROW CULTURED STROMAL CELLS REGULATE MYELOMA TUMOR GROWTH IN-VITRO - STUDIES WITH PRIMARY TUMOR-CELLS AND LTBMC-DEPENDENT CELL-LINES
Authors: BLOEM AC LAMME T DESMET M KOK H VOOIJS W WIJDENES J BOOM SE LOKHORST HM
Citation: Ac. Bloem et al., LONG-TERM BONE-MARROW CULTURED STROMAL CELLS REGULATE MYELOMA TUMOR GROWTH IN-VITRO - STUDIES WITH PRIMARY TUMOR-CELLS AND LTBMC-DEPENDENT CELL-LINES, British Journal of Haematology, 100(1), 1998, pp. 166-175
LUNG-RESISTANCE-RELATED PROTEIN EXPRESSION IS A NEGATIVE PREDICTIVE FACTOR FOR RESPONSE TO CONVENTIONAL LOW BUT NOT TO INTENSIFIED DOSE ALKYLATING CHEMOTHERAPY IN MULTIPLE-MYELOMA
Authors: RAAIJMAKERS HGP IZQUIERDO MAI LOKHORST HM DELEEUW C BELIEN JAM BLOEM AC DEKKER AW SCHEPER RJ SONNEVELD P
Citation: Hgp. Raaijmakers et al., LUNG-RESISTANCE-RELATED PROTEIN EXPRESSION IS A NEGATIVE PREDICTIVE FACTOR FOR RESPONSE TO CONVENTIONAL LOW BUT NOT TO INTENSIFIED DOSE ALKYLATING CHEMOTHERAPY IN MULTIPLE-MYELOMA, Blood, 91(3), 1998, pp. 1029-1036
PULSED HIGH-DOSE DEXAMETHASONE TREATMENT OF POLYNEUROPATHY ASSOCIATEDWITH MONOCLONAL GAMMOPATHY
Authors: NOTERMANS NC VERMEULEN M LOKHORST HM VANDOORN PA VANDENBERG LH TEUNISSEN LL WOKKE JHJ
Citation: Nc. Notermans et al., PULSED HIGH-DOSE DEXAMETHASONE TREATMENT OF POLYNEUROPATHY ASSOCIATEDWITH MONOCLONAL GAMMOPATHY, Journal of neurology, 244(7), 1997, pp. 462-463
DRUG-RESISTANCE IN MULTIPLE-MYELOMA
Authors: SONNEVELD P LOKHORST HM VOSSEBELD P
Citation: P. Sonneveld et al., DRUG-RESISTANCE IN MULTIPLE-MYELOMA, Seminars in hematology, 34(4), 1997, pp. 34-39
MODULATION OF CHRONIC EXCESSIVE INTERLEUKIN-6 PRODUCTION IN MULTIPLE-MYELOMA DOES NOT AFFECT THYROID-HORMONE CONCENTRATIONS
Authors: VANZAANEN HCT ROMIJN JA SAUERWEIN HP LOKHORST HM WARNAAR SO AARDEN LA ENDERT E VANOERS MHJ
Citation: Hct. Vanzaanen et al., MODULATION OF CHRONIC EXCESSIVE INTERLEUKIN-6 PRODUCTION IN MULTIPLE-MYELOMA DOES NOT AFFECT THYROID-HORMONE CONCENTRATIONS, Metabolism, clinical and experimental, 46(11), 1997, pp. 1343-1348
ANTIADHESIVE SIGNALS ARE MEDIATED VIA MAJOR HISTOCOMPATIBILITY COMPLEX CLASS-II MOLECULES IN NORMAL AND NEOPLASTIC HUMAN B-CELLS - CORRELATION WITH B-CELL DIFFERENTIATION STAGE
Authors: AHSMANN EJM BOOM SE LOKHORST HM RIJKSEN G BLOEM AC
Citation: Ejm. Ahsmann et al., ANTIADHESIVE SIGNALS ARE MEDIATED VIA MAJOR HISTOCOMPATIBILITY COMPLEX CLASS-II MOLECULES IN NORMAL AND NEOPLASTIC HUMAN B-CELLS - CORRELATION WITH B-CELL DIFFERENTIATION STAGE, European Journal of Immunology, 27(10), 1997, pp. 2688-2695
VAD ADMINISTERED AS INTRAVENOUS PUSH INJECTION AS FIRST-LINE TREATMENT IN STAGE II III MULTIPLE-MYELOMA/
Authors: SEGEREN CM VANDERHOLT B SONNEVELD P CROOCKEWIT S VELLENGA E VANOERS MHJ RICHEL D VERHOEF G CORNELISSEN JJ LOKHORST HM
Citation: Cm. Segeren et al., VAD ADMINISTERED AS INTRAVENOUS PUSH INJECTION AS FIRST-LINE TREATMENT IN STAGE II III MULTIPLE-MYELOMA/, Blood, 90(10), 1997, pp. 1591-1591
ALLOGENEIC VERSUS AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR REFRACTORY AND RECURRENT LOW-GRADE NON-HODGKINS-LYMPHOMA
Authors: VERDONCK LF DEKKER AW LOKHORST HM PETERSEN EJ NIEUWENHUIS HK
Citation: Lf. Verdonck et al., ALLOGENEIC VERSUS AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR REFRACTORY AND RECURRENT LOW-GRADE NON-HODGKINS-LYMPHOMA, Blood, 90(10), 1997, pp. 4201-4205
DONOR LEUKOCYTE INFUSIONS ARE EFFECTIVE IN RELAPSED MULTIPLE-MYELOMA AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION
Authors: LOKHORST HM SCHATTENBERG A CORNELISSEN JJ THOMAS LLM VERDONCK LF
Citation: Hm. Lokhorst et al., DONOR LEUKOCYTE INFUSIONS ARE EFFECTIVE IN RELAPSED MULTIPLE-MYELOMA AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION, Blood, 90(10), 1997, pp. 4206-4211
GRAFT-VERSUS-MYELOMA EFFECT IN 2 CASES
Authors: VERDONCK LF LOKHORST HM DEKKER AW NIEUWENHUIS HK PETERSEN EJ
Citation: Lf. Verdonck et al., GRAFT-VERSUS-MYELOMA EFFECT IN 2 CASES, Lancet, 347(9004), 1996, pp. 800-801
INTERMITTENT CYCLOPHOSPHAMIDE AND PREDNISONE TREATMENT OF POLYNEUROPATHY ASSOCIATED WITH MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE
Authors: NOTERMANS NC LOKHORST HM FRANSSEN H VANDERGRAAF Y TEUNISSEN LL JENNEKENS FGI VANDENBERG LH WOKKE JHJ
Citation: Nc. Notermans et al., INTERMITTENT CYCLOPHOSPHAMIDE AND PREDNISONE TREATMENT OF POLYNEUROPATHY ASSOCIATED WITH MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE, Neurology, 47(5), 1996, pp. 1227-1233
ENDOGENOUS INTERLEUKIN-6 PRODUCTION IN MULTIPLE-MYELOMA PATIENTS TREATED WITH CHIMERIC MONOCLONAL ANTI-IL6 ANTIBODIES INDICATES THE EXISTENCE OF A POSITIVE FEEDBACK LOOP
Authors: VANZAANEN HCT KOOPMANS RP AARDEN LA RENSINK HJAM STOUTHARD JML WARNAAR SO LOKHORST HM VANOERS MHJ
Citation: Hct. Vanzaanen et al., ENDOGENOUS INTERLEUKIN-6 PRODUCTION IN MULTIPLE-MYELOMA PATIENTS TREATED WITH CHIMERIC MONOCLONAL ANTI-IL6 ANTIBODIES INDICATES THE EXISTENCE OF A POSITIVE FEEDBACK LOOP, The Journal of clinical investigation, 98(6), 1996, pp. 1441-1448
INTERMEDIATE-DOSE MELPHALAN (IDM) COMBINED WITH G-CSF (FILGRASTIM) ISAN EFFECTIVE AND SAFE INDUCTION THERAPY FOR AUTOLOGOUS STEM-CELL, TRANSPLANTATION IN MULTIPLE-MYELOMA
Authors: LOKHORST HM SONNEVELD P WIJERMANS PW KOOY MV MEUWISSEN OJAT VANOERS RHJ VANDERGRIEND R DEKKER AW
Citation: Hm. Lokhorst et al., INTERMEDIATE-DOSE MELPHALAN (IDM) COMBINED WITH G-CSF (FILGRASTIM) ISAN EFFECTIVE AND SAFE INDUCTION THERAPY FOR AUTOLOGOUS STEM-CELL, TRANSPLANTATION IN MULTIPLE-MYELOMA, British Journal of Haematology, 92(1), 1996, pp. 44-48
CHRONIC IDIOPATHIC AXONAL POLYNEUROPATHY - COMPARISON OF PATIENTS WITH AND WITHOUT MONOCLONAL GAMMOPATHY
Authors: NOTERMANS NC WOKKE JHJ VANDENBERG LH VANDERGRAAF Y FRANSSEN H TEUNISSEN LL LOKHORST HM
Citation: Nc. Notermans et al., CHRONIC IDIOPATHIC AXONAL POLYNEUROPATHY - COMPARISON OF PATIENTS WITH AND WITHOUT MONOCLONAL GAMMOPATHY, Brain, 119, 1996, pp. 421-427
DIFFERENT CD44 SPLICING PATTERNS DEFINE PROGNOSTIC SUBGROUPS IN MULTIPLE-MYELOMA
Authors: STAUDER R VANDRIEL M SCHWARZLER C THALER J LOKHORST HM KREUSER ED BLOEM AC GUNTHERT U EISTERER W
Citation: R. Stauder et al., DIFFERENT CD44 SPLICING PATTERNS DEFINE PROGNOSTIC SUBGROUPS IN MULTIPLE-MYELOMA, Blood, 88(8), 1996, pp. 3101-3108
CYCLOSPORINE FOR THROMBOTIC THROMBOCYTOPENIC PURPURA AFTER AUTOLOGOUSBONE-MARROW TRANSPLANTATION
Authors: VANOJIK H VERDONCK LF FIJNHEER R HENE RJ LOKHORST HM ROODA SJE BIESMA DH
Citation: H. Vanojik et al., CYCLOSPORINE FOR THROMBOTIC THROMBOCYTOPENIC PURPURA AFTER AUTOLOGOUSBONE-MARROW TRANSPLANTATION, Blood, 88(10), 1996, pp. 645-645
Risultati: 1-25 | 26-42